|
1
|
Matsuba HM, Simpson JR, Mauney M and
Thawley SE: Adenoid cystic salivary gland carcinoma: A
clinicopathologic correlation. Head Neck Surg. 8:200–204. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rapidis AD, Givalos N, Gakiopoulou H,
Faratzis G, Stavrianos SD, Vilos GA, Douzinas EE and Patsouris E:
Adenoid cystic carcinoma of the head and neck. Clinicopathological
analysis of 23 patients and review of the literature. Oral Oncol.
41:328–335. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ampil FL and Misra RP: Factors influencing
survival of patients with adenoid cystic carcinoma of the salivary
glands. J Oral Maxillofac Surg. 45:1005–1010. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shimoda M, Sugiura T, Imajyo I, Ishii K,
Chigita S, Seki K, Kobayashi Y and Shirasuna K: The T-box
transcription factor Brachyury regulates epithelial-mesenchymal
transition in association with cancer stem-like cells in adenoid
cystic carcinoma cells. BMC Cancer. 12:3772012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simonetti M, Agarwal N, Stösser S, Bali
KK, Karaulanov E, Kamble R, Pospisilova B, Kurejova M, Birchmeier
W, Niehrs C, et al: Wnt-Fzd signaling sensitizes peripheral sensory
neurons via distinct noncanonical pathways. Neuron. 83:104–121.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agarwal JP, Jain S, Gupta T, Tiwari M,
Laskar SG, Dinshaw KA, Chaturvedi P, D'cruz AK and Shrivastava SK:
Intraoral adenoid cystic carcinoma: Prognostic factors and outcome.
Oral Oncol. 44:986–993. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng D, Decker KF, Zhou T, Chen J, Qi Z,
Jacobs K, Weilbaecher KN, Corey E, Long F and Jia L: Role of
WNT7B-induced noncanonical pathway in advanced prostate cancer. Mol
Cancer Res. 11:482–493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
García Campelo MR, Alonso Curbera G,
Aparicio Gallego G, Grande Pulido E and Antón Aparicio LM: Stem
cell and lung cancer development: Blaming the Wnt, Hh and Notch
signalling pathway. Clin Transl Oncol. 13:77–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pez F, Lopez A, Kim M, Wands JR, Caron de
Fromentel C and Merle P: Wnt signaling and hepatocarcinogenesis:
Molecular targets for the development of innovative anticancer
drugs. J Hepatol. 59:1107–1117. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dijksterhuis JP, Petersen J and Schulte G:
WNT/Frizzled signalling: receptor-ligand selectivity with focus on
FZD-G protein signalling and its physiological relevance: IUPHAR
Review 3. Br J Pharmacol. 171:1195–1209. 2014. View Article : Google Scholar :
|
|
12
|
Wang Y and Zheng T: Screening of hub genes
and pathways in colorectal cancer with microarray technology.
Pathol Oncol Res. 20:611–618. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Milovanovic T, Planutis K, Nguyen A, Marsh
JL, Lin F, Hope C and Holcombe RF: Expression of Wnt genes and
frizzled 1 and 2 receptors in normal breast epithelium and
infiltrating breast carcinoma. Int J Oncol. 25:1337–1342.
2004.PubMed/NCBI
|
|
14
|
Goksel G, Bilir A, Uslu R, Akbulut H,
Guven U and Oktem G: WNT1 gene expression alters in heterogeneous
population of prostate cancer cells; decreased expression pattern
observed in CD133+/CD44+ prostate cancer stem
cell spheroids. J BUON. 19:207–214. 2014.PubMed/NCBI
|
|
15
|
Ulivieri A, Lavra L, Dominici R,
Giacomelli L, Brunetti E, Sciacca L, Trovato M, Barresi G, Foukakis
T, Jia-Jing L, et al: Frizzled-1 is down-regulated in follicular
thyroid tumours and modulates growth and invasiveness. J Pathol.
215:87–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Su BH, Qu J, Song M, Huang XY, Hu XM, Xie
J, Zhao Y, Ding LC, She L, Chen J, et al: NOTCH1 signaling
contributes to cell growth, anti-apoptosis and metastasis in
salivary adenoid cystic carcinoma. Oncotarget. 5:6885–6895. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jinek M and Doudna JA: A three-dimensional
view of the molecular machinery of RNA interference. Nature.
457:405–412. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Snead NM and Rossi JJ: RNA interference
trigger variants: Getting the most out of RNA for RNA
interference-based therapeutics. Nucleic Acid Ther. 22:139–146.
2012.PubMed/NCBI
|
|
20
|
Kanasty RL, Whitehead KA, Vegas AJ and
Anderson DG: Action and reaction: The biological response to siRNA
and its delivery vehicles. Mol Ther. 20:513–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Győrffy B, Surowiak P, Budczies J and
Lánczky A: Online survival analysis software to assess the
prognostic value of biomarkers using transcriptomic data in
non-small-cell lung cancer. PLoS One. 8:e822412013. View Article : Google Scholar
|
|
22
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sriuranpong V, Borges MW, Ravi RK, Arnold
DR, Nelkin BD, Baylin SB and Ball DW: Notch signaling induces cell
cycle arrest in small cell lung cancer cells. Cancer Res.
61:3200–3205. 2001.PubMed/NCBI
|
|
24
|
Gujral TS, Chan M, Peshkin L, Sorger PK,
Kirschner MW and MacBeath G: A noncanonical Frizzled2 pathway
regulates epithelial-mesenchymal transition and metastasis. Cell.
159:844–856. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
MacDonald BT, Hien A, Zhang X, Iranloye O,
Virshup DM, Waterman ML and He X: Disulfide bond requirements for
active Wnt ligands. J Biol Chem. 289:18122–18136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kahn M: Can we safely target the WNT
pathway? Nat Rev Drug Discov. 13:513–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Daniels DL and Weis WI: Beta-catenin
directly displaces Groucho/TLE repressors from Tcf/Lef in
Wnt-mediated transcription activation. Nat Struct Mol Biol.
12:364–371. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
van de Schans VA, Smits JF and
Blankesteijn WM: The Wnt/frizzled pathway in cardiovascular
development and disease: Friend or foe? Eur J Pharmacol.
585:338–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Königshoff M, Balsara N, Pfaff EM, Kramer
M, Chrobak I, Seeger W and Eickelberg O: Functional Wnt signaling
is increased in idiopathic pulmonary fibrosis. PLoS One.
3:e21422008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Prakash S, Sarran L, Socci N, DeMatteo RP,
Eisenstat J, Greco AM, Maki RG, Wexler LH, LaQuaglia MP, Besmer P,
et al: Gastrointestinal stromal tumors in children and young
adults: A clinicopathologic, molecular, and genomic study of 15
cases and review of the literature. J Pediatr Hematol Oncol.
27:179–187. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li C, Chen H, Hu L, Xing Y, Sasaki T,
Villosis MF, Li J, Nishita M, Minami Y and Minoo P: Ror2 modulates
the canonical Wnt signaling in lung epithelial cells through
cooperation with Fzd2. BMC Mol Biol. 9:11–22. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kirikoshi H, Sekihara H and Katoh M:
Expression profiles of 10 members of Frizzled gene family in human
gastric cancer. Int J Oncol. 19:767–771. 2001.PubMed/NCBI
|
|
33
|
Stefansson S and Lawrence DA: The serpin
PAI-1 inhibits cell migration by blocking integrin alpha V beta 3
binding to vitronectin. Nature. 383:441–443. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Degryse B, Neels JG, Czekay RP, Aertgeerts
K, Kamikubo Y and Loskutoff DJ: The low density lipoprotein
receptor-related protein is a motogenic receptor for plasminogen
activator inhibitor-1. J Biol Chem. 279:22595–22604. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Garg N, Goyal N, Strawn TL, Wu J, Mann KM,
Lawrence DA and Fay WP: Plasminogen activator inhibitor-1 and
vitronectin expression level and stoichiometry regulate vascular
smooth muscle cell migration through physiological collagen
matrices. J Thromb Haemost. 8:1847–1854. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu J, Peng L, McMahon GA, Lawrence DA and
Fay WP: Recombinant plasminogen activator inhibitor-1 inhibits
intimal hyperplasia. Arterioscler Thromb Vasc Biol. 29:1565–1570.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brandal S, Blake CM, Sullenger BA and
Fortenberry YM: Effects of plasminogen activator
inhibitor-1-specific RNA aptamers on cell adhesion, motility, and
tube formation. Nucleic Acid Ther. 21:373–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
